🇺🇸 FDA
Patent

US 10953031

Compounds and methods for treating neurological and cardiovascular conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 10953031 (Compounds and methods for treating neurological and cardiovascular conditions) held by The Board of Regents of the University of Texas System expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P25/00